2017
DOI: 10.1016/j.micinf.2017.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Messages from the first International Conference on Clinical Metagenomics (ICCMg)

Abstract: Background: It has been suggested that prophages in the ST398 S. aureus clone are responsible for expanding ST398's spectrum of action and increasing its ability to cause human infections. We carried out the first characterization of the various prophages carried by 76 ST398 bloodstream infection (BSI) isolates obtained over 9 years of observation. Results: Whole-genome sequencing of 22 representative isolates showed (1) the presence of the φ3-prophage and diverse genetic features typical of animal-associated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(7 citation statements)
references
References 49 publications
0
7
0
Order By: Relevance
“…However, in the foreseeable future, the management of many aspects of diverticular disease will take into consideration the intestinal microbiome. First, metagenomics is rapidly entering clinical practice, and many ongoing studies will contribute to define the reference standards for gut microbiota composition and the clinical significance of dysbiosis [4]. From this perspective, clinical profiling of the gut microbiota will allow a personalized management of several intestinal and extraintestinal diseases, including diverticulosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, in the foreseeable future, the management of many aspects of diverticular disease will take into consideration the intestinal microbiome. First, metagenomics is rapidly entering clinical practice, and many ongoing studies will contribute to define the reference standards for gut microbiota composition and the clinical significance of dysbiosis [4]. From this perspective, clinical profiling of the gut microbiota will allow a personalized management of several intestinal and extraintestinal diseases, including diverticulosis.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have focused on the possible role of the gut microbiota. The emergence of culture-independent methods of microbial profiling has in fact improved the understanding of the extreme complexity of both fecal and mucosa-associated microbiota [3,4], highlighting its fundamental role in the onset and regulation of inflammation [5]. The pathophysiological role of the intestinal microbiota has been extensively studied for other gastrointestinal diseases, such as inflammatory bowel disease (IBD) [6] and colon cancer [7,8], and even for extraintestinal diseases, including metabolic syndrome [9], neurodegenerative diseases [10], kidney stones [11] and muscle-wasting disorders [12,13].…”
Section: Introductionmentioning
confidence: 99%
“…Though wet-laboratory workflows and data analysis pipelines combined with regulatory requirements are rapidly evolving, continued improvements are nonetheless needed. International conferences have recently been developed to discuss key aspects related to CMg [ 142 ]. Thus, as we move towards a CMg era, diagnostic laboratories should consider implementing the assay into practice particularly when standard microbiological testing fails to identify the putative pathogen.…”
Section: Discussionmentioning
confidence: 99%
“…At present, the cause of 60% infectious diseases is still unclear [1]. Clinical metagenomics is a detection technology that uses high-throughput sequencing technology to clarify the classification and function of all microorganisms in a sample without relying on traditional microbial culture [2,3]. is technology can simultaneously detect bacteria, fungi, viruses, and parasites in the same sample without any bias and does not require specific amplification.…”
Section: Current Research Statusmentioning
confidence: 99%